Activation of the MAPK/ERK Cell-Signaling Pathway in Uterine Smooth Muscle Cells of Women With Adenomyosis
Authors:
- Isabelle StreuliISIsabelle Streuli
- Pietro SantulliPSPietro Santulli
- Frédéric BatteuxFBFrédéric Batteux
- 30 December 2015
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 22 (12) , 1549-1560
Abstract
We investigated whether the myometrium might be intrinsically different in women with adenomyosis. We studied whether the mitogen-activated protein kinases/extracellular signal-regulated kinases (MAPKs/ERKs) and phosphoinositide 3-kinase/mammalian target of rapamycin/AKT (PI3K/mTOR/AKT) cell-signaling pathways, implicated in the pathogenesis of endometriosis, might also be activated in uterine smooth muscle cells (uSMCs) of women with adenomyosis and measured the production of reactive oxygen species (ROS), proinflammatory mediators that modulate cell proliferation and have been shown to activate the MAPK/ERK pathway in endometriosis. The uSMC cultures were derived from myometrium biopsies obtained during hysterectomy or myomectomy in women with adenomyosis and controls with leiomyoma. Proliferation of uSMCs and in vitro activation of the MAPK/ERK cell-signaling pathway were increased in women with adenomyosis compared to controls. The activation of the PI3K/mTOR/AKT pathway was not significant. The ROS production and ROS detoxification pathways were not different between uSMCs of women with adenomyosis and controls suggesting an ROS-independent activation of the MAPK/ERK pathway. Our results also provide evidence that protein kinase inhibitors and the rapanalogue temsirolimus can control proliferation of uSMCs in vitro suggesting an implication of the MAPK/ERK and the PI3K/mTOR/AKT pathways in proliferation of uSMCs in women with adenomyosis and leiomyomas.Keywords
This publication has 46 references indexed in Scilit:
- Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosisReproduction, 2013
- Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathwayProceedings of the National Academy of Sciences, 2013
- The pathophysiology of uterine adenomyosis: an updateFertility and Sterility, 2012
- The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in MiceThe American Journal of Pathology, 2011
- Reactive Oxygen Species Mediate Mitogenic Growth Factor Signaling Pathways in Human Leiomyoma Smooth Muscle Cells1Biology of Reproduction, 2010
- The pathophysiology of endometriosis and adenomyosis: tissue injury and repairArchives of Gynecology and Obstetrics, 2009
- Reactive Oxygen Species Controls Endometriosis ProgressionThe American Journal of Pathology, 2009
- Progestins Activate the AKT Pathway in Leiomyoma Cells and Promote SurvivalThe Journal of Clinical Endocrinology & Metabolism, 2009
- ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell MetastasisScience, 2008
- Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosisAnnals of the Rheumatic Diseases, 2007